A Prospective, With One Site, Open-label Not Controled Trial, for the Observation of Treatment With CIDOFOVIR 1%, 3 Nights Per Week, During 4 Weeks, of Anal Intraepithelial Neoplasia, High Level, in HIV+ Patients
- Conditions
- HIV
- Interventions
- First Posted Date
- 2013-09-19
- Last Posted Date
- 2016-06-29
- Lead Sponsor
- Fundacion SEIMC-GESIDA
- Target Recruit Count
- 20
- Registration Number
- NCT01946009
- Locations
- 🇪🇸
Hospital Universitario La Paz, Madrid, Spain
Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy
- Conditions
- HIV Infection
- Interventions
- First Posted Date
- 2011-03-03
- Last Posted Date
- 2015-05-12
- Lead Sponsor
- Fundacion SEIMC-GESIDA
- Target Recruit Count
- 286
- Registration Number
- NCT01307488
- Locations
- 🇪🇸
Hospital de Elche, Elche, Alicante, Spain
🇪🇸Hospital General de Granollers, Granollers, Barcelona, Spain
🇪🇸Hospital Marina Baixa, Villajoyosa, Alicante, Spain
Anidulafungin vs Amphotericin B Safety in High Risk Hepatic Transplant Recipients
- Conditions
- Liver DiseaseFungal Infection
- Interventions
- First Posted Date
- 2011-02-24
- Last Posted Date
- 2014-05-30
- Lead Sponsor
- Fundacion SEIMC-GESIDA
- Target Recruit Count
- 61
- Registration Number
- NCT01303549
- Locations
- 🇪🇸
Hospital de Bellvitge, Barcelona, Spain
🇪🇸Hospital Vall d'Hebrón, Barcelona, Spain
🇪🇸Hospital Clinic i Provincial, Barcelona, Spain
Prospective Population Study on Candidemia in Spain
- Conditions
- Fungemia
- Interventions
- Other: Non intervention
- First Posted Date
- 2010-11-07
- Last Posted Date
- 2013-04-23
- Lead Sponsor
- Fundacion SEIMC-GESIDA
- Target Recruit Count
- 730
- Registration Number
- NCT01236261
- Locations
- 🇪🇸
Hospital Infanta Leonor, Madrid, Spain
🇪🇸Hospital Puerta de Hierro Majadahonda, Majadahonda, Madrid, Spain
🇪🇸Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
HCV Evolution in HIV/HCV (Genotype 1) Coinfected Patients Treated With Fosamprenavir
- First Posted Date
- 2010-10-18
- Last Posted Date
- 2014-05-30
- Lead Sponsor
- Fundacion SEIMC-GESIDA
- Target Recruit Count
- 42
- Registration Number
- NCT01222611
- Locations
- 🇪🇸
Hospital Clínico San Carlos, Madrid, Spain
🇪🇸Hospital Gregorio Marañón, Madrid, Spain
🇪🇸Hospital La Paz, Madrid, Spain
Treatment of HIV/HCV Coinfection With Peg-IFN and Ribavirin in Patients Receiving ART Monotherapy With Lopinavir/r
- Conditions
- HIV/HCV Co-infectionHIV Infections
- Interventions
- Drug: Lopinavir/ritonavir with two nucleoside analogs
- First Posted Date
- 2009-03-20
- Last Posted Date
- 2025-03-17
- Lead Sponsor
- Fundacion SEIMC-GESIDA
- Target Recruit Count
- 68
- Registration Number
- NCT00866021
- Locations
- 🇪🇸
Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain
🇪🇸Hospital General de Castellón, Castellón De La Plana, Castellón, Spain
🇪🇸Hospital Donostia, San Sebastian, Guipuzcoa, Spain
Prevention of Lipoatrophy in Patients Treated With Lopinavir/Ritonavir in Monotherapy Versus ZDV + 3TC + ABC
- Conditions
- HIV InfectionHIV Infections
- Interventions
- Drug: AZT+3TC+ABV (Trizivir)Drug: Switching to LPV/r monotherapy (Kaletra)
- First Posted Date
- 2009-03-19
- Last Posted Date
- 2013-09-12
- Lead Sponsor
- Fundacion SEIMC-GESIDA
- Target Recruit Count
- 38
- Registration Number
- NCT00865475
- Locations
- 🇪🇸
Hospital de Basurto, Bilbao, Vizcaya, Spain
🇪🇸Hospital Severo Ochoa, Leganes, Madrid, Spain
🇪🇸Hospital Ntra.Sra. de Zumarraga, Zumarraga, Guipuzcua, Spain
Lopinavir/r Monotherapy Versus Abacavir/Lamivudine and Lopinavir/r for Limb Fat Recovery in Persons With Lipoatrophy
- Conditions
- HIV InfectionLipodystrophyHIV Infections
- Interventions
- Drug: Monotherapy (Lopinavir/ritonavir)Drug: Monotherapy (Lopinavir/ritonavir) + ABC/3TC
- First Posted Date
- 2009-03-19
- Last Posted Date
- 2013-03-22
- Lead Sponsor
- Fundacion SEIMC-GESIDA
- Target Recruit Count
- 88
- Registration Number
- NCT00865007
- Locations
- 🇪🇸
Hospital General Universitario de Alicante, Alicante, Spain
🇪🇸Hospital Severo Ochoa, Leganes, Madrid, Spain
🇪🇸Hospital Xeral Cies, Vigo, Pontevedra, Spain